• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by ETHZilla Corporation

    11/4/25 5:29:40 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ETHZ alert in real time by email
    DEFA14A 1 ea0261719-03.htm PROXY STATEMENT

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    __________________________________________

    SCHEDULE 14A

    __________________________________________

    Proxy Statement Pursuant to Section 14(a)
    of the Securities Exchange Act of 1934
    (Amendment No.    )

    Filed by the Registrant

     

    ☒

    Filed by party other than the registrant

     

    ☐

    Check the appropriate box:

    ☐

     

    Preliminary Proxy Statement

    ☐

     

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐

     

    Definitive Proxy Statement

    ☒

     

    Definitive Additional Materials

    ☐

     

    Soliciting Material under § 240 14a-12

    ETHZILLA CORPORATION
    (Name of Registrant as Specified in its Charter)

    Payment of Filing Fee (Check all boxes that apply):

    ☒

     

    No fee required

    ☐

     

    Fee paid previously with preliminary materials

    ☐

     

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

    ETHZILLA CORPORATION CONTROL ID: REQUEST ID: IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SPECIAL MEETING OF STOCKHOLDERS DATE: TUESDAY, DECEMBER 16, 2025 TIME: 9:00 A.M. PACIFIC STANDARD TIME LOCATION: https://edge.media-server.com/mmc/go/ethz2025SGM HOW TO REQUEST PAPER COPIES OF OUR MATERIALS PHONE: CALL TOLL FREE 1-866-752-8683 FAX: SEND THIS CARD TO 202-521-3464 INTERNET: HTTPS://WWW.IPROXYDIRECT.COM/ETHZ AND FOLLOW THE ON-SCREEN INSTRUCTIONS. EMAIL: [email protected] INCLUDE YOUR CONTROL ID IN YOUR EMAIL. THIS COMMUNICATION REPRESENTS A NOTICE TO ACCESS A MORE COMPLETE SET OF PROXY MATERIALS AVAILABLE TO YOU ON THE INTERNET. WE ENCOURAGE YOU TO ACCESS AND REVIEW ALL OF THE IMPORTANT INFORMATION CONTAINED IN THE PROXY MATERIALS BEFORE VOTING. THE PROXY STATEMENT IS AVAILABLE AT: HTTPS://WWW.IPROXYDIRECT.COM/ETHZ IF YOU WANT TO RECEIVE A PAPER COPY OF THE PROXY MATERIALS YOU MUST REQUEST ONE. THERE IS NO CHARGE TO YOU FOR REQUESTING A COPY. TO FACILITATE TIMELY DELIVERY PLEASE MAKE THE REQUEST, AS INSTRUCTED ABOVE, BEFORE NOVEMBER 30, 2025. YOU MAY ENTER YOUR VOTING INSTRUCTIONS AT HTTPS://WWW.IPROXYDIRECT.COM/ETHZ UNTIL 11:59 PM EASTERN TIME DECEMBER 15, 2025. THE PURPOSES OF THIS MEETING ARE AS FOLLOWS: 1. TO APPROVE FOR PURPOSES OF COMPLYING WITH SECTION 5635(D) OF THE LISTING RULES (THE “NASDAQ LISTING RULES”) OF THE NASDAQ STOCK MARKET LLC, THE ISSUANCE OF SHARES OF THE COMPANY’S COMMON STOCK UNDERLYING SENIOR SECURED CONVERTIBLE NOTES ISSUED BY US PURSUANT TO THE TERMS OF THAT CERTAIN AMENDMENT AND WAIVER AGREEMENT DATED SEPTEMBER 22, 2025, BETWEEN THE COMPANY AND THE INVESTORS NAMED THEREIN, WITHOUT GIVING EFFECT TO THE EXCHANGE CAP IN SUCH SENIOR SECURED CONVERTIBLE NOTES IN AN AMOUNT THAT MAY BE EQUAL TO OR EXCEED 20% OF OUR COMMON STOCK OUTSTANDING IMMEDIATELY PRIOR TO THE ISSUANCE OF SUCH SENIOR SECURED CONVERTIBLE NOTES (THE “CN NASDAQ 20% CAP REMOVAL PROPOSAL”); AND 2. TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING, IF NECESSARY. PURSUANT TO SECURITIES AND EXCHANGE COMMISSION RULES, YOU ARE RECEIVING THIS NOTICE THAT THE PROXY MATERIALS FOR THE SPECIAL MEETING ARE AVAILABLE ON THE INTERNET. FOLLOW THE INSTRUCTIONS ABOVE TO VIEW THE MATERIALS AND VOTE OR REQUEST PRINTED COPIES. THE BOARD OF DIRECTORS HAS FIXED THE CLOSE OF BUSINESS ON OCTOBER 17, 2025 AS THE RECORD DATE FOR THE DETERMINATION OF STOCKHOLDERS ENTITLED TO RECEIVE NOTICE OF THE SPECIAL MEETING AND TO VOTE THE SHARES OF OUR COMMON STOCK, PAR VALUE $0.0001 PER SHARE, THEY HELD ON THAT DATE AT THE MEETING OR ANY POSTPONEMENT OR ADJOURNMENT OF THE MEETING. THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE ‘FOR’ ALL PROPOSALS ABOVE. PLEASE NOTE - THIS IS NOT A PROXY CARD - YOU CANNOT VOTE BY RETURNING THIS CARD

     

    C/O ISSUER DIRECT COMPLIANCE 1110 CENTRE POINT CURVE STE 101 MENDOTA HEIGHTS MN 55120 TIME SENSITIVE SHAREHOLDER INFORMATION ENCLOSED IMPORTANT SHAREHOLDER INFORMATION YOUR VOTE IS IMPORTANT FIRST-CLASS MAIL US POSTAGE PAID DURHAM NC PERMIT # 302

     

    Get the next $ETHZ alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ETHZ

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ETHZ
    SEC Filings

    View All

    SEC Form S-8 filed by ETHZilla Corporation

    S-8 - ETHZilla Corp (0001690080) (Filer)

    11/6/25 5:12:31 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 25-NSE filed by ETHZilla Corporation

    25-NSE - ETHZilla Corp (0001690080) (Subject)

    11/5/25 4:14:57 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by ETHZilla Corporation

    DEF 14A - ETHZilla Corp (0001690080) (Filer)

    11/5/25 9:20:44 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ETHZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ETHZilla Sells Approximately $40mm ETH to Facilitate Stock Repurchases

    Company has repurchased approximately 600k shares for about $12 million since Oct. 24, 2025 Company is buying back shares at a significant discount to NAV PALM BEACH, Fla., Oct. 27, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ)("ETHZilla" or the "Company"), a technology company connecting traditional finance and decentralized finance, today announced that it sold approximately $40 million of its ETH treasury holdings and plans to use the proceeds for share repurchases. Since executing the sale on Oct. 24, 2025, the Company has repurchased approximately 600,000 shares of its common stock for approximately $12 million under its existing board authorized $250 million stock repurchase

    10/27/25 4:00:00 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Announces Third Quarter 2025 Earnings Release Date and Webcast Details

    PALM BEACH, Fla., Oct. 24, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ), a leading technology company connecting traditional finance with decentralized finance, today announced it expects to release its financial results for the third quarter ended Sept. 30, 2025, before the U.S. markets open on Friday, Nov. 14, 2025. McAndrew Rudisill, chairman and chief executive officer, and John Saunders, vice president, finance, will host a live webcast on the same day at 10:30 a.m. EST, to discuss third quarter results and operational updates. To register and listen to the liv

    10/24/25 2:34:00 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Announces Strategic Partnership with Liquidity.io

    Accelerates ETHZilla's ability to securitize real-world assets on-chain  Offers exchange capabilities to expand investor access to compliant digital securities ETHZilla to take a 15% equity stake in Satschel, Inc. to further align interests PALM BEACH, Fla., Oct. 23, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ) ("ETHZilla" or the "Company"), a technology company bridging traditional finance and decentralized finance, today announced a strategic partnership with Liquidity.io, a regulated broker-dealer and operator of a Digital Alternative Trading System (ATS), and a wholly owned subsidiary of Satschel, Inc. The partnership is expected to accelerate ETHZilla's institutional-grade to

    10/23/25 8:00:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ETHZ
    Leadership Updates

    Live Leadership Updates

    View All

    ETHZilla names John Kristoff as SVP, Corporate Communications and Investor Relations

    PALM BEACH, Fla., Oct. 16, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ), a leading technology company connecting traditional finance with decentralized finance, today announced the appointment of John D. Kristoff as Senior Vice President, Corporate Communications and Investor Relations. He will report directly to Chairman and CEO McAndrew Rudisill. In this newly created role, Kristoff will lead ETHZilla's communications and investor relations strategies, shaping the company's narrative and deepening engagement with both the media and investors. He will also play a k

    10/16/25 8:00:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Announces Appointment of Jason New to Board of Directors

    PALM BEACH, Fla., Oct. 8, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ) ("ETHZilla" or the "Company"), today announced that Jason New, Vice Chairman of Investment Banking at Lazard, has been appointed as a member of its Board of Directors, effective immediately. Mr. New brings more than two decades of experience in global credit, private equity, and alternative investments. He previously co-founded NovaWulf Management, a digital-asset investment and infrastructure platform, and served as Chief Executive Officer of Onex Credit Partners, a $25 billion alternative credi

    10/8/25 7:59:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care